Suzhou Industrial Park Heshun Electric
300141
Guangdong Xiongsu Technology Group
300599
Sichuan Chuanhuan Technology
300547
Shanghai Wisdom Information Technology
301315
KANGNONG SEED
837403
CN Stock MarketDetailed Quotes
300039 Shanghai Kaibao Pharmaceutical
- 6.48
- +0.11+1.73%
Market Closed Dec 27 15:00 CST
6.78BMarket Cap19.46P/E (TTM)
6.51High6.33Low148.35KlotVolume6.37Open6.37Pre Close95.65MTurnover1.62%Turnover Ratio20.70P/E (Static)1.05BShares7.6052wk High1.76P/B5.94BFloat Cap4.9052wk Low7.64Limit Up916.93MShs Float18.28Historical High5.10Limit Down2.83%Amplitude2.60Historical Low0.10Dividend TTM6.45Avg Price59.47KlotAsk1.54%Div YieldTTM100Lot Size85.66KlotBid
Shanghai Kaibao Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -2.87%1.12B | -2.03%829.15M | 3.51%475.5M | 42.47%1.59B | 44.29%1.15B | 56.68%846.35M | 33.61%459.39M | 1.66%1.12B | 0.64%800.01M | 0.40%540.17M |
| Operating revenue | -2.87%1.12B | -2.03%829.15M | 3.51%475.5M | 42.47%1.59B | 44.29%1.15B | 56.68%846.35M | 33.61%459.39M | 1.66%1.12B | 0.64%800.01M | 0.40%540.17M |
| Other operating revenue | ---- | -84.56%145.23K | ---- | 34.59%3.03M | ---- | -32.59%940.74K | ---- | 73.95%2.25M | ---- | 328.75%1.4M |
| Interest income | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Commission income | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Premiums earned | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Total operating cost | -5.47%876.74M | -3.74%662.73M | 3.00%375.46M | 39.78%1.24B | 40.52%927.49M | 55.20%688.47M | 34.93%364.52M | -5.39%887.78M | -0.59%660.04M | 0.62%443.59M |
| Operating cost | -12.91%209.65M | -15.53%152.82M | -1.15%88.49M | 26.22%312.48M | 39.85%240.74M | 47.75%180.92M | 25.46%89.52M | 5.39%247.57M | 6.48%172.14M | 15.92%122.45M |
| Operating tax surcharges | -9.66%15.71M | -5.93%12.37M | 0.16%7.15M | 41.44%23.92M | 51.79%17.39M | 60.92%13.16M | 36.46%7.14M | 47.13%16.92M | 44.09%11.46M | 58.72%8.17M |
| Operating expense | -9.23%512.98M | -3.66%399.2M | -0.31%235.72M | 40.19%777.07M | 31.64%565.18M | 49.51%414.37M | 32.02%236.46M | -6.76%554.29M | -0.87%429.35M | -3.41%277.15M |
| Administration expense | 16.55%65.74M | 6.59%41.37M | 29.33%21.02M | 38.40%81.06M | 43.82%56.41M | 47.57%38.81M | 28.57%16.25M | 0.63%58.57M | -20.49%39.22M | -19.09%26.3M |
| Financial expense | -2.29%-29.61M | -4.10%-18.95M | -4.19%-9.31M | -16.33%-49.48M | -2.60%-28.95M | -18.16%-18.2M | -8.90%-8.93M | -6.22%-42.54M | -40.45%-28.22M | -10.40%-15.4M |
| -Interest expense (Financial expense) | --14.7K | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Interest Income (Financial expense) | -2.38%-29.72M | -4.14%-19.01M | -4.29%-9.34M | -16.26%-49.6M | -2.59%-29.03M | -18.09%-18.25M | -8.76%-8.95M | -5.77%-42.66M | -39.59%-28.29M | -9.56%-15.46M |
| Research and development | 33.29%102.27M | 27.78%75.93M | 34.50%32.38M | 81.01%95.87M | 112.59%76.73M | 138.38%59.42M | 140.34%24.08M | -33.23%52.97M | 12.84%36.09M | 1.43%24.93M |
| Credit Impairment Loss | 33.33%5.95M | 403.80%4.23M | 98.24%-115.82K | 178.37%5.33M | 7,105.53%4.46M | -205.95%-1.39M | -5.84%-6.56M | -104.04%-6.8M | 125.47%61.91K | 190.36%1.31M |
| Asset Impairment Loss | -98.78%1.7K | -99.61%1.7K | -99.52%1.7K | -143.16%-12.24M | -63.98%139.74K | -1.29%432.3K | 32.86%353.63K | -29.60%-5.03M | 181,053.68%387.99K | 204,380.69%437.96K |
| Other net revenue | 0.94%12.13M | -53.77%2.78M | 0.18%1.1M | 1,201.90%29.84M | 176.24%12.01M | 59.57%6.01M | 122.25%1.1M | -128.19%-2.71M | -65.14%4.35M | 15.88%3.76M |
| Fair value change income | -1,093.76%-3.62M | -563.04%-7.11M | -150.14%-1.77M | 49.41%-678.31K | 105.97%363.83K | 159.29%1.53M | 514.96%3.52M | -184.36%-1.34M | -228.03%-6.1M | -197.59%-2.59M |
| Invest income | 41.05%4.69M | -17.15%2.45M | -39.21%1.32M | 314.66%11.27M | -1.00%3.33M | 163.22%2.95M | 586.52%2.17M | -218.52%-5.25M | 336.22%3.36M | 176.20%1.12M |
| Net open hedge income | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Including: Investment income associates | ---- | ---- | --0 | 49.18%-4.55M | ---- | ---- | --0 | ---8.96M | ---- | ---- |
| Exchange income | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Asset deal income | ---11.92K | ---11.92K | ---11.92K | -18.61%-206.64K | ---- | ---- | --0 | 20.50%-174.22K | 74.52%-11.44K | 61.52%-11.44K |
| Other revenue | 37.34%5.11M | 29.60%3.21M | 3.77%1.67M | 65.94%26.37M | -44.01%3.72M | -28.95%2.48M | 4.98%1.61M | 44.18%15.89M | -8.02%6.65M | -1.84%3.49M |
| Operating profit | 7.44%256.62M | 3.24%169.19M | 5.39%101.14M | 67.69%382.96M | 65.51%238.86M | 63.32%163.89M | 39.63%95.97M | 32.90%228.37M | 0.60%144.32M | -0.09%100.35M |
| Add:Non operating Income | -96.02%2.03K | 123.94%1.86K | --1.33K | 2,033.17%1.08M | 96.83%50.93K | -96.72%830 | --0 | 117.69%50.76K | --25.87K | --25.29K |
| Less:Non operating expense | -36.24%153.63K | -64.06%50K | --0 | -77.18%508.01K | -59.73%240.95K | -49.23%139.11K | -63.50%100K | 1.21%2.23M | -54.16%598.31K | 19.13%274K |
| Total profit | 7.46%256.47M | 3.30%169.15M | 5.50%101.14M | 69.56%383.53M | 66.03%238.67M | 63.59%163.75M | 39.99%95.87M | 33.33%226.19M | 1.12%143.75M | -0.11%100.1M |
| Less:Income tax cost | -7.01%39.83M | -4.98%27.24M | -18.46%12.84M | 56.86%56.63M | 66.66%42.84M | 60.85%28.67M | 38.90%15.75M | 22.23%36.11M | -3.56%25.7M | -3.20%17.82M |
| Net profit | 10.62%216.64M | 5.05%141.9M | 10.21%88.3M | 71.98%326.9M | 65.90%195.83M | 64.18%135.08M | 40.21%80.12M | 35.67%190.08M | 2.20%118.04M | 0.59%82.27M |
| Net profit from continuing operation | 10.62%216.64M | 5.05%141.9M | 10.21%88.3M | 71.98%326.9M | 65.90%195.83M | 64.18%135.08M | 40.21%80.12M | 35.67%190.08M | 2.20%118.04M | 0.59%82.27M |
| Net income from discontinuing operating | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Less:Minority Profit | -47.19%-430.68K | -13.08%-235.68K | -163.11%-159.79K | -35.09%-972.31K | 48.52%-292.59K | 58.65%-208.42K | 87.70%-60.73K | -30,953.27%-719.74K | ---568.37K | ---504.01K |
| Net profit of parent company owners | 10.68%217.07M | 5.07%142.14M | 10.33%88.46M | 71.84%327.87M | 65.35%196.12M | 63.44%135.29M | 39.11%80.18M | 36.18%190.8M | 2.70%118.61M | 1.21%82.78M |
| Earning per share | ||||||||||
| Basic earning per share | 10.67%0.2075 | 5.10%0.1359 | 10.30%0.0846 | 71.88%0.3135 | 65.34%0.1875 | 63.46%0.1293 | 39.20%0.0767 | 36.12%0.1824 | 2.72%0.1134 | 1.15%0.0791 |
| Diluted earning per share | 10.67%0.2075 | 5.10%0.1359 | 10.30%0.0846 | 71.88%0.3135 | 65.34%0.1875 | 63.46%0.1293 | 39.20%0.0767 | 36.12%0.1824 | 2.72%0.1134 | 1.15%0.0791 |
| Other composite income | -294.20%-290M | -1,094.68%-559.4M | -224.75%-341.46M | -99.14%4.35M | -112.57%-73.57M | -95.80%56.24M | 152.63%273.71M | 42.08%508.45M | 56.86%585.31M | 1.34B |
| Other composite income of parent company owners | -294.20%-290M | -1,094.68%-559.4M | -224.75%-341.46M | -99.14%4.35M | -112.57%-73.57M | -95.80%56.24M | 152.63%273.71M | 42.08%508.45M | 56.86%585.31M | --1.34B |
| Other composite income of minority owners | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Total composite income | -160.00%-73.36M | -318.22%-417.5M | -171.55%-253.16M | -52.58%331.25M | -82.62%122.26M | -86.53%191.32M | 113.81%353.83M | 40.28%698.53M | 43.94%703.35M | 1,637.02%1.42B |
| Total composite income of parent company owners | -159.51%-72.93M | -317.86%-417.26M | -171.49%-253M | -52.49%332.22M | -82.59%122.56M | -86.52%191.53M | 113.21%353.89M | 40.42%699.25M | 44.06%703.92M | 1,637.64%1.42B |
| Total composite income of minority owners | -47.19%-430.68K | -13.08%-235.68K | -163.11%-159.79K | -35.09%-972.31K | 48.52%-292.59K | 58.65%-208.42K | 87.70%-60.73K | -30,953.27%-719.74K | ---568.37K | ---504.01K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
